Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

Sarah L Tansley, Zoe E Betteridge, Gavin Shaddick, Harsha Gunawardena, Katie Arnold, Lucy R Wedderburn, Neil J McHugh, on behalf of the Juvenile Dermatomyositis Research Group

Research output: Contribution to journalArticle

67 Citations (Scopus)
35 Downloads (Pure)

Abstract

Objective. Calcinosis is a major cause of morbidity in JDM and has previously been linked to anti-NXP2 autoantibodies, younger age at disease onset and more persistent disease activity. This study aimed to investigate the clinical associations of anti-NXP2 autoantibodies in patients with JDM stratified by age at disease onset.

Methods. A total of 285 patients with samples and clinical data were recruited via the UK Juvenile Dermatomyositis Cohort and Biomarker Study. The presence of anti-NXP2 was determined by both immunoprecipitation and ELISA. Logistic regression analysis was performed to assess the age-dependent relationship between anti-NXP2 and the development of calcinosis and disease activity measures.

Results. We identified anti-NXP2 autoantibodies in 56 patients (20%). While in all patients younger age at disease onset was associated with an increased risk of calcinosis and this relationship was nearly linear, anti-NXP2 autoantibodies substantially increased the risk of calcinosis across all ages (P = 0.025) and were detectable prior to calcinosis development. Children with anti-NXP2 autoantibodies had a greater degree of weakness (median lowest ever Childhood Myositis Assessment Score 29.6 vs 42) and were less likely to be in remission at 2 years post-diagnosis. No difference in disease activity was seen 4 years post-diagnosis.

Conclusion. Children diagnosed at a young age have a high risk of calcinosis regardless of autoantibody status. However, the presence of anti-NXP2 autoantibodies substantially increases the risk of calcinosis across all ages and is associated with disease severity.
Original languageEnglish
Pages (from-to)2204-2208
Number of pages5
JournalRheumatology
Volume53
Issue number12
Early online date1 Jul 2014
DOIs
Publication statusPublished - 1 Dec 2014

Keywords

  • juvenile dermatomyositis
  • autoantibody
  • calcinosis
  • age

Fingerprint Dive into the research topics of 'Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset'. Together they form a unique fingerprint.

  • Cite this

    Tansley, S. L., Betteridge, Z. E., Shaddick, G., Gunawardena, H., Arnold, K., Wedderburn, L. R., McHugh, N. J., & on behalf of the Juvenile Dermatomyositis Research Group (2014). Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology, 53(12), 2204-2208. https://doi.org/10.1093/rheumatology/keu259